Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| TORVASTATIN FC TABLET 40MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TORVASTATIN FC TABLET 40MG | Feb 9, 2026 | SIN17457P |
| TORVASTATIN FC TABLET 80MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TORVASTATIN FC TABLET 80MG | Feb 9, 2026 | SIN17456P |
| ESOMEPRAZOLE AUXILTO GASTRO-RESISTANT TABLETS 40MG | AUXILTO IMPEX PTE. LTD. | ESOMEPRAZOLE AUXILTO GASTRO-RESISTANT TABLETS 40MG | Feb 9, 2026 | SIN17454P |
| TORVASTATIN FC TABLET 10MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TORVASTATIN FC TABLET 10MG | Feb 9, 2026 | SIN17459P |
| TORVASTATIN FC TABLET 20MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TORVASTATIN FC TABLET 20MG | Feb 9, 2026 | SIN17458P |
| ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML | SANOFI-AVENTIS SINGAPORE PTE. LTD. | ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML | Feb 9, 2026 | SIN17460P |
| Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL | SCIGEN PTE. LTD. | Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL | Feb 4, 2026 | SIN17453P |
| TRANEXAMIC ACID MEVON FILM-COATED TABLETS 500 MG | NOVEM HEALTHCARE PTE LTD | TRANEXAMIC ACID MEVON FILM-COATED TABLETS 500 MG | Feb 3, 2026 | SIN17452P |
| RIVAROXABAN-TEVA FC TABLET 2.5MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | RIVAROXABAN-TEVA FC TABLET 2.5MG | Feb 2, 2026 | SIN17451P |
| RIVAROXABAN-TEVA FC TABLET 10MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | RIVAROXABAN-TEVA FC TABLET 10MG | Feb 2, 2026 | SIN17450P |
| RIVAROXABAN-TEVA FC TABLET 15MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | RIVAROXABAN-TEVA FC TABLET 15MG | Feb 2, 2026 | SIN17449P |
| RIVAROXABAN-TEVA FC TABLET 20MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | RIVAROXABAN-TEVA FC TABLET 20MG | Feb 2, 2026 | SIN17448P |
| MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL | MEDOCHEMIE SINGAPORE PTE. LTD. | MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL | Jan 27, 2026 | SIN17446P |
| JAMP-CHOLESTYRAMINE POWDER FOR ORAL SUSPENSION 4G | GOLDPLUS UNIVERSAL PTE LTD | JAMP-CHOLESTYRAMINE POWDER FOR ORAL SUSPENSION 4G | Jan 23, 2026 | SIN17445P |
| ZYGABALIN HARD CAPSULE 75MG | APEX PHARMA MARKETING PTE. LTD. | ZYGABALIN HARD CAPSULE 75MG | Jan 22, 2026 | SIN17443P |
| ZYGABALIN HARD CAPSULE 150MG | APEX PHARMA MARKETING PTE. LTD. | ZYGABALIN HARD CAPSULE 150MG | Jan 22, 2026 | SIN17442P |
| ZYGABALIN HARD CAPSULE 50MG | APEX PHARMA MARKETING PTE. LTD. | ZYGABALIN HARD CAPSULE 50MG | Jan 22, 2026 | SIN17444P |
| GP-KETOPROFEN PLASTER 30MG/PLASTER | GOLDPLUS UNIVERSAL PTE LTD | GP-KETOPROFEN PLASTER 30MG/PLASTER | Jan 16, 2026 | SIN17441P |
| JUBBONTI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 60MG/ML | SANDOZ SINGAPORE PTE. LTD. | JUBBONTI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 60MG/ML | Jan 15, 2026 | SIN17439P |
| EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G | PFIZER PRIVATE LIMITED | EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G | Jan 15, 2026 | SIN17438P |
